The Current and Emerging Role of Cardiovascular Magnetic Resonance in the Diagnosis of Nonischemic Cardiomyopathies

Progress in Cardiovascular Diseases

Volumn 54, Issue 3, 2011, Pages 253-265

  Karamitsos, Theodoros D ^a   Francis, Jane M ^a   Neubauer, Stefan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Fibrosis; Heart failure; Hypertrophy; Imaging; Late gadolinium enhancement; Systolic dysfunction; Tissue characterization

Indexed keywords

GADOLINIUM;

ARTICLE; BRUGADA SYNDROME; CHAGAS DISEASE; CHURG STRAUSS SYNDROME; CLINICAL PROTOCOL; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FABRY DISEASE; HEART AMYLOIDOSIS; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE DYSPLASIA; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; IRON OVERLOAD; MITOCHONDRIAL MYOPATHY; MYOCARDITIS; NONISCHEMIC CARDIOMYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIAL DISEASE; PERIPARTUM CARDIOMYOPATHY; PROGNOSIS; SARCOIDOSIS; TAKOTSUBO CARDIOMYOPATHY; VENTRICULAR NONCOMPACTION;

CARDIOMYOPATHIES; HUMANS; MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 80054785990     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2011.08.007     Document Type: Article

References (86)

1. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996, 93:841-842.
2. Maron B.J., Towbin J.A., Thiene G., et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006, 113:1807-1816.
3. Douglas P.S., Garcia M.J., Haines D.E., et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians. J Am Soc Echocardiogr 2011, 24:229-267.
4. Karamitsos T.D., Francis J.M., Myerson S., et al. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol 2009, 54:1407-1424.
5. Karamitsos T.D., Hudsmith L.E., Selvanayagam J.B., et al. Operator induced variability in left ventricular measurements with cardiovascular magnetic resonance is improved after training. J Cardiovasc Magn Reson 2007, 9:777-783.
6. Catalano O., Antonaci S., Opasich C., et al. Intra-observer and interobserver reproducibility of right ventricle volumes, function and mass by cardiac magnetic resonance. J Cardiovasc Med (Hagerstown) 2007, 8:807-814.
7. Piechnik S.K., Ferreira V.M., Dall'armellina E., et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010, 12:69.
8. Giri S., Chung Y.C., Merchant A., et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 2009, 11:56.
9. Anderson L.J., Holden S., Davis B., et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001, 22:2171-2179.
10. Karamitsos T.D., Neubauer S. Cardiovascular magnetic resonance in heart failure. Curr Cardiol Rep 2011, 13:210-219.
11. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100:1992-2002.
12. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343:1445-1453.
13. Iles L., Pfluger H., Phrommintikul A., et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008, 52:1574-1580.
14. Jerosch-Herold M., Sheridan D.C., Kushner J.D., et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2008, 295:H1234-H1242.
15. Flett A.S., Hayward M.P., Ashworth M.T., et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010, 122:138-144.
16. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003, 42:1687-1713.
17. Maron B.J., Maron M.S., Wigle E.D., et al. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy. J Am Coll Cardiol 2009, 54:191-200.
18. O'Brien K.R., Cowan B.R., Jain M., et al. MRI phase contrast velocity and flow errors in turbulent stenotic jets. J Magn Reson Imaging 2008, 28:210-218.
19. Moon J.C., Fisher N.G., McKenna W.J., et al. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 2004, 90:645-649.
20. Rickers C., Wilke N.M., Jerosch-Herold M., et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005, 112:855-861.
21. Maron M.S., Finley J.J., Bos J.M., et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 2008, 118:1541-1549.
22. Choudhury L., Mahrholdt H., Wagner A., et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002, 40:2156-2164.
23. Rudolph A., Abdel-Aty H., Bohl S., et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 2009, 53:284-291.
24. Yamada M., Teraoka K., Kawade M., et al. Frequency and distribution of late gadolinium enhancement in magnetic resonance imaging of patients with apical hypertrophic cardiomyopathy and patients with asymmetrical hypertrophic cardiomyopathy: a comparative study. Int J Cardiovasc Imaging 2009, 25(Suppl 1):131-138.
25. Moon J.C., Reed E., Sheppard M.N., et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004, 43:2260-2264.
26. O'Hanlon R., Grasso A., Roughton M., et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010, 56:867-874.
27. Petersen S.E., Jerosch-Herold M., Hudsmith L.E., et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 2007, 115:2418-2425.
28. Adabag A.S., Maron B.J., Appelbaum E., et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008, 51:1369-1374.
29. Papavassiliu T., Germans T., Fluchter S., et al. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation. J Cardiovasc Magn Reson 2009, 11:34.
30. Bruder O., Wagner A., Jensen C.J., et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010, 56:875-887.
31. Rubinshtein R., Glockner J.F., Ommen S.R., et al. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 2010, 3:51-58.
32. Valeti U.S., Nishimura R.A., Holmes D.R., et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2007, 49:350-357.
33. Karamitsos T.D., Dall'armellina E., Choudhury R.P., et al. Ischemic heart disease: comprehensive evaluation by cardiovascular magnetic resonance. Am Heart J 2011, 162:16-30.
34. McCrohon J.A., Moon J.C.., Prasad S.K., et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003, 108:54-59.
35. Roberts W.C., Siegel R.J., McManus B.M. Idiopathic dilated cardiomyopathy: Analysis of 152 necropsy patients. Am J Cardiol 1987, 60:1340-1355.
36. Marcus F.I., McKenna W.J., Sherrill D., et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010, 121:1533-1541.
37. Jain A., Tandri H., Calkins H., et al. Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia. J Cardiovasc Magn Reson 2008, 10:32.
38. Tandri H., Saranathan M., Rodriguez E.R., et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005, 45:98-103.
39. Hunold P., Wieneke H., Bruder O., et al. Late enhancement: a new feature in MRI of arrhythmogenic right ventricular cardiomyopathy?. J Cardiovasc Magn Reson 2005, 7:649-655.
40. Sen-Chowdhry S., Syrris P., Prasad S.K., et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol 2008, 52:2175-2187.
41. Friedrich M.G., Sechtem U., Schulz-Menger J., et al. Cardiovascular magnetic resonance in myocarditis: a JACC White paper. J Am Coll Cardiol 2009, 53:1475-1487.
42. Abdel-Aty H., Boye P., Zagrosek A., et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005, 45:1815-1822.
43. Mahrholdt H., Wagner A., Deluigi C.C., et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006, 114:1581-1590.
44. Mahrholdt H., Goedecke C., Wagner A., et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004, 109:1250-1258.
45. Murphy R.T., Thaman R., Blanes J.G., et al. Natural history and familial characteristics of isolated left ventricular non-compaction. Eur Heart J 2005, 26:187-192.
46. Monserrat L., Hermida-Prieto M., Fernandez X., et al. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur Heart J 2007, 28:1953-1961.
47. Petersen S.E., Selvanayagam J.B., Wiesmann F., et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005, 46:101-105.
48. Maceira A.M., Joshi J., Prasad S.K., et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005, 111:186-193.
49. Syed I.S., Glockner J.F., Feng D., et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 2010, 3:155-164.
50. Austin B.A., Tang W.H., Rodriguez E.R., et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging 2009, 2:1369-1377.
51. Maceira A.M., Prasad S.K., Hawkins P.N., et al. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 2008, 10:54.
52. Patel A.R., Klein M.R., Chandra S., et al. Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study. Eur J Heart Fail 2011, (Epub ahead of print).
53. Patel M.R., Cawley P.J., Heitner J.F., et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009, 120:1969-1977.
54. Schulz-Menger J., Wassmuth R., Abdel-Aty H., et al. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart 2006, 92:399-400.
55. Sachdev B., Takenaka T., Teraguchi H., et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 2002, 105:1407-1411.
56. Nakao S., Takenaka T., Maeda M., et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 1995, 333:288-293.
57. Moon J.C., Sachdev B., Elkington A.G., et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003, 24:2151-2155.
58. Moon J.C., Sheppard M., Reed E., et al. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson 2006, 8:479-482.
59. Mocumbi A.O., Yacoub S., Yacoub M.H. Neglected tropical cardiomyopathies: II. Endomyocardial fibrosis: myocardial disease. Heart 2008, 94:384-390.
60. Genee O., Fichet J., Alison D. Images in cardiovascular medicine: cardiac magnetic resonance imaging and eosinophilic endomyocardial fibrosis. Circulation 2008, 118:e710-e711.
61. Salemi V.M., Rochitte C.E., Shiozaki A.A., et al. Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients. Circ Cardiovasc Imaging 2011, 4:304-311.
62. Noth I., Strek M.E., Leff A.R. Churg-Strauss syndrome. Lancet 2003, 361:587-594.
63. Wassmuth R., Gobel U., Natusch A., et al. Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome. J Card Fail 2008, 14:856-860.
64. Wood J.C. Cardiac iron across different transfusion-dependent diseases. Blood Rev 2008, 22(Suppl 2):S14-S21.
65. Carpenter J.P., He T., Kirk P., et al. On T2* magnetic resonance and cardiac iron. Circulation 2011, 123:1519-1528.
66. Kirk P., Roughton M., Porter J.B., et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 2009, 120:1961-1968.
67. Karamitsos T.D., Bull S., Spyrou N., et al. Tako-tsubo cardiomyopathy presenting with features of left ventricular non-compaction. Int J Cardiol 2008, 128:e34-e36.
68. Abdel-Aty H., Cocker M., Friedrich M.G. Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: insights from T2-weighted cardiovascular magnetic resonance. Int J Cardiol 2009, 132:291-293.
69. Elesber A.A., Prasad A., Bybee K.A., et al. Transient cardiac apical ballooning syndrome: prevalence and clinical implications of right ventricular involvement. J Am Coll Cardiol 2006, 47:1082-1083.
70. Karamitsos T.D., Bull S., Ferreira V., et al. Acute myocarditis mimicking reverse Takotsubo cardiomyopathy. Circulation 2011, 123:226-227.
71. Ariyarajah V., Jassal D.S., Kirkpatrick I., et al. The utility of cardiovascular magnetic resonance in constrictive pericardial disease. Cardiol Rev 2009, 17:77-82.
72. Kojima S., Yamada N., Goto Y. Diagnosis of constrictive pericarditis by tagged cine magnetic resonance imaging. N Engl J Med 1999, 341:373-374.
73. Catalano O., Antonaci S., Moro G., et al. Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities. Eur Heart J 2009, 30:2241-2248.
74. Papavassiliu T., Wolpert C., Fluchter S., et al. Magnetic resonance imaging findings in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2004, 15:1133-1138.
75. Ntusi N.B., Mayosi B.M. Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int J Cardiol 2009, 131:168-179.
76. Pyatt J.R., Dubey G. Peripartum cardiomyopathy: current understanding, comprehensive management review and new developments. Postgrad Med J 2011, 87:34-39.
77. Marmursztejn J., Vignaux O., Goffinet F., et al. Delayed-enhanced cardiac magnetic resonance imaging features in peripartum cardiomyopathy. Int J Cardiol 2009, 137:e63-e64.
78. Mouquet F., Lions C., de Groote P., et al. Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Eur Radiol 2008, 18:2765-2769.
79. DiMauro S., Schon E.A. Mitochondrial respiratory-chain diseases. N Engl J Med 2003, 348:2656-2668.
80. Limongelli G., Tome-Esteban M., Dejthevaporn C., et al. Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. Eur J Heart Fail 2010, 12:114-121.
81. Nakanishi M., Harada M., Tadamura E., et al. Images in cardiovascular medicine. Mitochondrial cardiomyopathy evaluated with cardiac magnetic resonance. Circulation 2007, 116:e25-e26.
82. Partington S.L., Givertz M.M., Gupta S., et al. Cardiac magnetic resonance aids in the diagnosis of mitochondrial cardiomyopathy. Circulation 2011, 123:e227-e229.
83. Lescure F.X., Le Loup G., Freilij H., et al. Chagas disease: changes in knowledge and management. Lancet Infect Dis 2010, 10:556-570.
84. Rochitte C.E., Nacif M.S., de Oliveira Junior A.C., et al. Cardiac magnetic resonance in Chagas' disease. Artif Organs 2007, 31:259-267.
85. Rochitte C.E., Oliveira P.F., Andrade J.M., et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol 2005, 46:1553-1558.
86. McAteer M.A., Akhtar A.M., von Zur Muhlen C., et al. An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide. Atherosclerosis 2010, 209:18-27.